Pietro Bersani - Aug 11, 2022 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBP)

Signature
/s/ Pietro Bersani
Stock symbol
KRBP
Transactions as of
Aug 11, 2022
Transactions value $
$0
Form type
4
Date filed
8/15/2022, 04:23 PM
Next filing
Oct 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRBP Common Stock Award $0 +638K $0.00 638K Aug 11, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") and will be settled in common stock as soon as practicable within 60 days following vesting. The RSUs were granted pursuant to an executive employment agreement entered into by and between the reporting person and the issuer dated January 27, 2022, pursuant to which the reporting person was entitled to receive a grant of RSUs for the right to receive the number of shares of the issuer's common stock with an aggregate value of $600,000 based on the fair market value of the issuer's common stock as of January 27, 2022, which was $0.94 per share. 425,532 RSUs vested on August 11, 2022 and the remaining 212,766 RSUs will vest monthly in four equal installments beginning on September 27, 2022.